EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 1,940.00
+14.00 (0.73%)
At close: Sep 3, 2026
EyeGene Market Cap
EyeGene has a market cap or net worth of 86.03 billion as of September 4, 2026. Its market cap has increased by 10.89% in one year.
Market Cap
86.03B
Enterprise Value
46.90B
Revenue
4.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,940.00
ChartMarket Cap Chart
Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 86.03B, a decrease of -34.33%. That is a compound annual growth rate of -3.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 86.03B | 14.43% |
| Dec 30, 2025 | 75.18B | 8.64% |
| Dec 30, 2024 | 69.20B | -24.46% |
| Dec 28, 2023 | 91.61B | -15.21% |
| Dec 29, 2022 | 108.04B | -73.58% |
| Dec 30, 2021 | 408.92B | 175.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 98.04B |
| Choong Ang Vaccine Laboratory | 86.00B |
| BIO-FD&C | 76.70B |
| IMGT Co.,Ltd. | 76.11B |
| SunBio,Inc. | 75.72B |
| CTCBIO | 74.48B |
| AriBioLab | 69.05B |
| ADBiotech | 68.59B |